NCT05672576Active, not recruitingPhase 3
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy
Source: ClinicalTrials.gov · Last updated 30 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer are: * How well cenerimod works on top of the treatment already being administered. * How safe cenerimod is for adult patients with Systemic Lupus Erythematosus. Researchers will compare one dose of cenerimod and a placebo to see how well cenerimod works when it is added to the treatment already being administered. In this research study approximately 210 participants will receive cenerimod and approximately 210 participants will receive placebo for 12 months.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 451 (actual)
- First submitted
- 3 Jan 2023
- Start date
- 26 Jun 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Viatris Innovation GmbH
- Diseases
- Lupus (SLE)
- NCT number
- NCT05672576
- EU CT number
- 2024-515871-37-00
- EudraCT number
- 2022-002815-47
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 451
- From 26 Jun 2023 to the primary completion date, 31 Dec 2026
- 146 sites in 18 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Signed Informed Consent Form (ICF) prior to any study-mandated procedure.
- Diagnosis of Systemic Lupus Erythematosus (SLE) made at least 6 months prior to Screening, according to 2019 European League Against Rheumatism / American College of Rheumatology Criteria.
- A modified Systemic Lupus Erythematosus Disease Activity Index-2000 (mSLEDAI-2K) score ≥ 6 and clinical mSLEDAI-2K score ≥ 4 with at least 2 points for musculoskeletal or mucocutaneous manifestations (i.e., myositis, arthritis, rash, alopecia, mucosal ulcers). The mSLEDAI-2K score does not include "leukopenia".
- British Isles Lupus Assessment Group-2004 (BILAG) Grade B in ≥ 2 organ systems or a BILAG Grade A in ≥ 1 organ system.
- Physician's Global Assessment (PGA) score ≥ 1.0 on a 0 to 3 visual analog scale.
- Currently treated with one or more of the following SLE background medications:
- Anti-malarials (≤ 400 mg/day hydroxychloroquine, ≤ 500 mg/day chloroquine, ≤ 100 mg/day quinacrine).
- Mycophenolate mofetil (≤ 2 g/day) / mycophenolic acid (≤1.44 g/day).
- Azathioprine (≤ 2 mg/kg/day).
- Methotrexate (≤ 25 mg/week).
- Oral Corticosteroids (OCS):
- if OCS is the only SLE background medication: ≥ 7.5 mg/day and ≤ 30 mg/day prednisone or equivalent.
- if OCS is not the only SLE background medication: ≤ 30 mg/day prednisone or equivalent.
- Belimumab (≤10 mg/kg every 4 weeks intravenously \[i.v.\], or 200 mg/week subcutaneously \[s.c.\]).
- Treatment with antimalarials, mycophenolate mofetil, mycophenolic acid, azathioprine, methotrexate or belimumab must have been started at least 90 days prior to Screening. Treatment with OCS must have been started at least 30 days prior to Screening.
- For women of childbearing potential (WoCBP):
- Negative serum pregnancy test at Screening.
- Agreement to undertake monthly urine pregnancy tests from Randomization up to 6 months after study treatment discontinuation.
- Agreement to use a highly effective method of contraception from Screening (Visit 1) up to 6 months after study treatment discontinuation.
- A clinical mSLEDAI-2K score ≥ 4 with at least 2 points for musculoskeletal or mucocutaneous manifestations (i.e., myositis, arthritis, rash, alopecia, mucosal ulcers).
- BILAG Grade B in 2 or more organ systems or a BILAG Grade A in 1 or more organ system.
- PGA score ≥ 1.0 on a 0 to 3 visual analog scale.
- Presence of at least one of the following biomarkers of serological evidence of active SLE (in a Screening sample as measured by central laboratory):
- Anti-dsDNA antibodies elevated above normal,
- Antinuclear antibodies with a titer of at least 1:160,
- Anti-Smith antibody elevated above normal.
- Currently treated with one or more of the following SLE background medications that must be stable for at least 30 days prior to Randomization (except OCS, which must be stable for at least 15 days prior to Randomization):
- Antimalarials (≤ 400 mg/day hydroxychloroquine, ≤ 500 mg/day chloroquine, ≤ 100 mg/day quinacrine);
- Mycophenolate mofetil (≤ 2 g/day) / mycophenolic acid (≤ 1.44g/day);
- Azathioprine (≤ 2 mg/kg/day);
- Methotrexate (≤ 25 mg/week);
- OCS:
- if OCS is the only SLE background medication: ≥ 7.5 mg/day and ≤ 30 mg/day prednisone or equivalent.
- if OCS is not the only SLE background medication: ≤ 30 mg/day prednisone or equivalent.
- Belimumab (≤ 10 mg/kg every 4 weeks i.v. or ≤ 200 mg/week s.c.).
- WoCBP must have a negative urine pregnancy test at Randomization.
- Main Exclusion Criteria:
- Pregnant, planning to be become pregnant up to Final Study Visit, or lactating women.
- Severe active central nervous system lupus or active severe or unstable neuropsychiatric SLE including but not limited to: aseptic meningitis; cerebral vasculitis; myelopathy; demyelination syndromes (ascending, transverse, acute inflammatory demyelinating polyradiculopathy); acute confusional state; impaired level of consciousness; psychosis; acute stroke or stroke syndrome; cranial neuropathy; status epilepticus; cerebellar ataxia; or mononeuritis multiplex:
- That would make the subject unable to fully understand the ICF; OR
- Where, in the opinion of the investigator/delegate, protocol-specified standard of care is insufficient and the use of a more aggressive therapeutic approach, such as adding i.v. cyclophosphamide and/or high dose i.v. pulse corticosteroid (CS) therapy or other treatments not permitted in the protocol is indicated.
- A diagnosis of mixed connective tissue disease or any history of overlap syndromes of SLE with psoriasis, rheumatoid arthritis, erosive arthritis, scleroderma, autoimmune hepatitis or uncontrolled autoimmune thyroid disease.
- History or presence of Mobitz type II or third-degree atrioventricular block, sick sinus syndrome, symptomatic bradycardia or syncope associated with cardiac disorders.
- Subjects who experienced myocardial infarction, unstable angina pectoris, stroke, transient ischemic attack, vascular thrombosis, decompensated heart failure requiring hospitalization, or heart failure defined by the New York Heart Association Class III/IV within 6 months prior to Screening.
- Resting heart rate \< 50 bpm as measured by the 12-lead ECG at Screening or at Randomization.
- An elevated QT interval corrected according to Fridericia's formula (QTcF) interval of \> 470 ms (females) / \> 450 ms (males) at Screening or at Randomization.
- History or presence of severe respiratory disease or pulmonary fibrosis, based on medical history, lung function, and chest X-ray (or CT scan as per local guidelines), performed at Screening or within 6 months prior to Screening.
- History of clinically relevant bronchial asthma or chronic obstructive pulmonary disease that has required treatment with oral or parenteral CS for more than a total of 2 weeks within the last 6 months prior to Screening.
- History or presence of malignancy (except for surgically excised and non-recurrent cutaneous basal cell carcinoma, squamous cell carcinoma, or cervical carcinoma), lymphoproliferative disease, or history of total lymphoid irradiation within 10 years prior to Screening.
- Presence of any of the following abnormalities detected during the ophthalmological evaluation and/or by optical coherence tomography (OCT) during screening:
- Macular edema of any cause: diabetic, cystoid, tractional.
- Foveal degeneration, macular hole, macular pseudohole, hereditary or degenerative maculopathies.
- Active uveitis, papilledema.
- Retinal neovascularization of any cause and in any location.
- History of chronic liver or biliary disease (other than Gilbert's Syndrome) or subjects with alanine aminotransferase or aspartate aminotransferase \> 3 × Upper Limit of Normal (ULN) or total bilirubin \> 1.5 × ULN (unless in the context of known Gilbert's Syndrome).
- Significant hematology abnormality at screening assessment:
- lymphocyte count \< 500 /μL (0.5 × 10\^9/L);
- hemoglobin \< 7 g/dL;
- white blood cell count \< 2000/μL (2.0 × 10\^9/L); or
- platelets \< 25000/μL (25 × 10\^9/L).
- Estimated glomerular filtration rate \< 15 mL/min/1.73 m\^2.
- Treatment with the following medications within 15 days or 5 half-lives of the medication (whichever is longer) prior to Randomization:
- β-blockers, diltiazem, verapamil, digoxin, digitoxin, or any other antiarrhythmic or heart-rate -lowering systemic therapy.
- QT-prolonging drugs with known risk of torsade de pointes irrespective of indication.
- Treatment with the following medications within 30 days or 5 half-lives of the medication (whichever is longer) prior to Randomization:
- Cyclophosphamide, cyclosporine, voclosporin, tacrolimus, sirolimus, etc.
- Pulse methylprednisolone.
- Vaccination with live vaccines (including live vaccines for COVID-19).
- Intra-articular, intramuscular or i.v. CS within 6 weeks prior to Randomization.
- Treatment with the following medications within 90 days or 5 half-lives of the medication (whichever is longer) prior to Randomization:
- Leflunomide.
- i.v. immunoglobulins.
- Treatment with any investigational agent within 90 days or 5 half-lives of the drug (whichever is longer) prior to Randomization.
- Treatment with B cell-depleting biological agents (e.g., rituximab or ocrelizumab) or biological immunosuppressive agents (e.g., anti-tumor necrosis factor \[TNF\], anti-interleukin \[IL\]-1, anti-IL6 therapies), within 12 months prior to Randomization.
- Treatment with anifrolumab within 6 months prior to Randomization.
- Treatment with any of the following medications any time prior to Screening:
- Alemtuzumab,
- Sphingosine-1-phosphate receptor modulators (e.g., fingolimod),
- Subjects previously randomized to cenerimod or placebo in any trial involving cenerimod.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (146)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sociedad Médica del Aparato Locomotor S. A. Coordinator of this site? Confirm its status | Providencia | Chile | Unknown status |
| Biomedica Research Group Coordinator of this site? Confirm its status | Providencia | Chile | Unknown status |
| Enroll SpA Coordinator of this site? Confirm its status | Santiago | Chile | Unknown status |
| Estudios G y C Ltda Coordinator of this site? Confirm its status | Santiago | Chile | Unknown status |
| Centro de especialidades médicas Vanguardia Coordinator of this site? Confirm its status | Temuco | Chile | Unknown status |
| Clinical Research Chile Spa. Coordinator of this site? Confirm its status | Valdivia | Chile | Unknown status |
| Hospital San José de Victoria Coordinator of this site? Confirm its status | Victoria | Chile | Unknown status |
| iMedica s.r.o. Coordinator of this site? Confirm its status | Brno | Czechia | Active, not recruiting |
| Revmatologicky Ustav Coordinator of this site? Confirm its status | Prague 2 | Czechia | Active, not recruiting |
| Fraunhofer Institute For Translational Medicine And Pharmacology ITMP Coordinator of this site? Confirm its status | Frankfurt Am Main | Germany | Active, not recruiting |
| Universitaetsklinikum Leipzig Aor Coordinator of this site? Confirm its status | Leipzig | Germany | Active, not recruiting |
| Johannes Wesling Klinikum Minden Coordinator of this site? Confirm its status | Minden | Germany | Active, not recruiting |
| Universitaetsklinikum Muenster AöR Coordinator of this site? Confirm its status | Muenster | Germany | Active, not recruiting |
| Accellacare Espana S.L. Coordinator of this site? Confirm its status | Alcobendas | Spain | Active, not recruiting |
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Active, not recruiting |
| Hospital Universitario Infanta Leonor Coordinator of this site? Confirm its status | Madrid | Spain | Active, not recruiting |
| Hospital Clínico San Carlos Coordinator of this site? Confirm its status | Madrid | Spain | Active, not recruiting |
| Hospital Universitario Ramón y Cajal Coordinator of this site? Confirm its status | Madrid | Spain | Active, not recruiting |
| Parc Tauli Hospital Universitari Coordinator of this site? Confirm its status | Sabadell | Spain | Active, not recruiting |
| Clínica Gaias - Santiago Coordinator of this site? Confirm its status | Santiago de Compostela | Spain | Active, not recruiting |
| Hospital Quironsalud Sagrado Corazon Coordinator of this site? Confirm its status | Sevilla | Spain | Active, not recruiting |
| Hospital Clinico Universitario de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Active, not recruiting |
| Hospital Universitario Dr. Peset Aleixandre Coordinator of this site? Confirm its status | Valencia | Spain | Active, not recruiting |
| Hospital Universitario Rio Hortega Coordinator of this site? Confirm its status | Valladolid | Spain | Active, not recruiting |
| University Hospitals of Leicester NHS Trust Coordinator of this site? Confirm its status | Leicester | United Kingdom | Unknown status |
| Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| LTD "New Plasma Clinic" Coordinator of this site? Confirm its status | Batumi | Georgia | Unknown status |
| LTD Tbilisi Heart Center Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| LLC Raymann Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| The First Medical Center LTD Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Ltd. Mtskheta Street Clinic Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Aversi Clinic LTD Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| LTD "Tbilisi Central Hospital" Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| National Institute of Endocrinology, LTD, Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| LLC "Innova" Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Medi Club Georgia Ltd. Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Institute of Clinical Cardiology, Ltd. Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Caucasus Medical Centre Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Tbilisi Institute of Medicine Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| JSC Jerarsi Clinic Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Tbilisi Heart and Vascular Clinic LTD Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
| Shalby Hospitals Coordinator of this site? Confirm its status | Ahmedabad | India | Unknown status |
| Chennai Meenakshi Multispeciality Hospital Pvt. Ltd. Coordinator of this site? Confirm its status | Chennai | India | Unknown status |
| ESIC Medical College and Hospital Coordinator of this site? Confirm its status | Hyderabad | India | Unknown status |
| IPGME&R and SSKM Hospital Coordinator of this site? Confirm its status | Kolkata | India | Unknown status |
| Jasleen Hospital Coordinator of this site? Confirm its status | Nagpur | India | Unknown status |
| Chopda Medicare & Research Centre Coordinator of this site? Confirm its status | Nashik | India | Unknown status |
| AIIMS, New Delhi Coordinator of this site? Confirm its status | New Delhi | India | Unknown status |
| Center for Rheumatic Diseases Coordinator of this site? Confirm its status | Pune | India | Unknown status |
| Yashoda Hospital Coordinator of this site? Confirm its status | Secunderabad | India | Unknown status |
| Nirmal Hospital Private Limited Coordinator of this site? Confirm its status | Surat | India | Unknown status |
| Consultorio Particular Dr. Miguel Cortés Hernández Coordinator of this site? Confirm its status | Cuernavaca | Mexico | Unknown status |
| Centro Integral en Reumatologia SA de CV (CIRSA) Coordinator of this site? Confirm its status | Guadalajara | Mexico | Unknown status |
| Morales Vargas Centro de Investigacion, S.C. Coordinator of this site? Confirm its status | León | Mexico | Unknown status |
| Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan S.C.P. (CEMDEICY S.C.P.) Coordinator of this site? Confirm its status | Mérida | Mexico | Unknown status |
| Boca Clinical Trials Mexico, S.C. Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| Centro de Investigacion Clínica GRAMEL S.C Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| Clinstile, S.A. de C.V. Coordinator of this site? Confirm its status | Mexico City | Mexico | Unknown status |
| UBAM Unidad Biomedica Avanzada Monterrey Coordinator of this site? Confirm its status | Monterrey | Mexico | Unknown status |
| Accelerium, S. de R.L. de C.V. Coordinator of this site? Confirm its status | Monterrey | Mexico | Unknown status |
| Oaxaca contra el Cáncer A.C Coordinator of this site? Confirm its status | Oaxaca City | Mexico | Unknown status |
| Centro de Estudios Clínicos de Querétaro S.C. Coordinator of this site? Confirm its status | Querétaro | Mexico | Unknown status |
| Clinical Research Institute S.C. Coordinator of this site? Confirm its status | Tlalnepantla | Mexico | Unknown status |
| PCR Toluca - Phylasis Clinical Research Coordinator of this site? Confirm its status | Toluca | Mexico | Unknown status |
| Hospital Selayang Coordinator of this site? Confirm its status | Batu Caves | Malaysia | Unknown status |
| Universiti Kebangsaan Malaysia Medical Centre Coordinator of this site? Confirm its status | Cheras | Malaysia | Unknown status |
| Hospital Tuanku Fauziah, Kangar Coordinator of this site? Confirm its status | Kangar | Malaysia | Unknown status |
| University of Malaya Medical Centre Coordinator of this site? Confirm its status | Kuala Lumpur | Malaysia | Unknown status |
| Sarawak General Hospital Coordinator of this site? Confirm its status | Kuching | Malaysia | Unknown status |
| Hospital Sibu, Sarawak Coordinator of this site? Confirm its status | Sibu | Malaysia | Unknown status |
| Unidad de Investigación en Medicina Interna y Enfermedades Críticas / Hogar Clínica San Juan de Dios Coordinator of this site? Confirm its status | Cayma | Peru | Unknown status |
| Centro de Investigación del Hospital Militar Central Coordinator of this site? Confirm its status | Jesus Maria | Peru | Unknown status |
| Centro de Investigacion Clinica Inmunoreumatologia / ACQ Medic SAC Coordinator of this site? Confirm its status | Jesús María | Peru | Unknown status |
| Alberto Sabogal Sologuren National Hospital Coordinator of this site? Confirm its status | Lima | Peru | Unknown status |
| Hospital Maria Auxiliadora Coordinator of this site? Confirm its status | Lima | Peru | Unknown status |
| Unidad de Investigación de la Clinica International Coordinator of this site? Confirm its status | San Borja | Peru | Unknown status |
| Clínica Anglo Americana Coordinator of this site? Confirm its status | San Isidro | Peru | Unknown status |
| Servicios Reumatológicos SOMA E.I.R.L. / Clinica El Golf Coordinator of this site? Confirm its status | San Isidro | Peru | Unknown status |
| Instituto Peruano del Hueso y la Articulación S.A.C. (IPHAR) Coordinator of this site? Confirm its status | San Isidro | Peru | Unknown status |
| Unidad de Investigación en Reumatología e Inmunología CSJB Coordinator of this site? Confirm its status | San Juan de Lurigancho | Peru | Unknown status |
| Hospital Nacional Cayetano Heredia Coordinator of this site? Confirm its status | San Martín de Porres | Peru | Unknown status |
| Investigaciones Clinicas / Instituto de Ginecología y Reproducción, El Derby Coordinator of this site? Confirm its status | Santiago de Surco | Peru | Unknown status |
| Centro de Investigación Clínica Trujillo EIRL / Clínica Peruano Americana S.A Coordinator of this site? Confirm its status | Trujillo | Peru | Unknown status |
| Iloilo Doctors Hospital Coordinator of this site? Confirm its status | Iloilo City | Philippines | Unknown status |
| Makati Medical Center Coordinator of this site? Confirm its status | Makati | Philippines | Unknown status |
| Ospital Ng Makati Coordinator of this site? Confirm its status | Makati City | Philippines | Unknown status |
| St Lukes Medical Center Coordinator of this site? Confirm its status | Manila | Philippines | Unknown status |
| The Medical City Clark Coordinator of this site? Confirm its status | Pampanga | Philippines | Unknown status |
| St Luke's Medical Center Quezon City / University of Santo Tomas Hospital Coordinator of this site? Confirm its status | Sampaloc | Philippines | Unknown status |
| Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy Coordinator of this site? Confirm its status | Bydgoszcz | Poland | Active, not recruiting |
| Santa SP. z o.o Coordinator of this site? Confirm its status | Lodz | Poland | Active, not recruiting |
| Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o.o. Coordinator of this site? Confirm its status | Poznan | Poland | Active, not recruiting |
| Ortopedyczno - Rehabilitacyjny Szpital Kliniczny im. Wiktora Degi Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu Coordinator of this site? Confirm its status | Poznan | Poland | Active, not recruiting |
| Piotr Leszczyński Medyczne Centrum Hetmańska Piotr Leszczyński Coordinator of this site? Confirm its status | Poznań | Poland | Active, not recruiting |
| Medicover Integrated Clinical Services Sp. z o.o. Coordinator of this site? Confirm its status | Warsaw | Poland | Active, not recruiting |
| Centro Reumatologico de Caguas Coordinator of this site? Confirm its status | Caguas | Puerto Rico | Unknown status |
| GCM Medical Group, PSC Coordinator of this site? Confirm its status | San Juan | Puerto Rico | Unknown status |
| Unidade Local De Saude De Amadora Sintra E.P.E. Coordinator of this site? Confirm its status | Amadora | Portugal | Active, not recruiting |
| Unidade Local de Saude do Algarve E.P.E. Coordinator of this site? Confirm its status | Faro | Portugal | Active, not recruiting |
| Unidade Local De Saude Da Guarda E.P.E. Coordinator of this site? Confirm its status | Guarda | Portugal | Active, not recruiting |
| Unidade Local De Saude Do Alto Ave E.P.E. Coordinator of this site? Confirm its status | Guimaraes | Portugal | Active, not recruiting |
| Instituto Portugues de Reumatologia Coordinator of this site? Confirm its status | Lisbon | Portugal | Active, not recruiting |
| Unidade Local De Saude De Lisboa Ocidental E.P.E. Coordinator of this site? Confirm its status | Lisbon | Portugal | Active, not recruiting |
| Unidade Local de Saúde de Gaia/Espinho, E. P. E Coordinator of this site? Confirm its status | Vila Nova de Gaia | Portugal | Active, not recruiting |
| Military Medical Academy Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
| Institute of Rheumatology, Belgrade (study site 2) Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
| University Clinical Center of Serbia Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
| Institute of Rheumatology, Belgrade (study site 1) Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
| Institute of Rheumatology, Belgrade (study site 3) Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
| Clinical Center Kragujevac Coordinator of this site? Confirm its status | Kragujevac | Serbia | Unknown status |
| Special Hospital For Rheumatic Diseases Novi Sad Coordinator of this site? Confirm its status | Novi Sad | Serbia | Unknown status |
| General Hospital - Djordje Joanovic Coordinator of this site? Confirm its status | Zrenjanin | Serbia | Unknown status |
| Communal Non-profit Enterprise "Chernihiv Regional Hospital" of the Chernihiv Regional Council, Rheumatology Department Coordinator of this site? Confirm its status | Chernihiv | Ukraine | Unknown status |
| St. Luke's Treatment and Diagnostic Center Coordinator of this site? Confirm its status | Ivano-Frankivsk | Ukraine | Unknown status |
| Medical Center of the Limited Liability Company "Edelweiss Medics", Treatment and Prevention Department Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| "Medbud-Clinic" LLC, Treatment and Prevention Department of the Medical Center Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Medical Center "Center of Family Medicine Plus" LLC, Treatment and Prevention Department Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Med Center "Ok!Clinic+" of Ltd Liability Com "Inter Ins of Clin Rsrch", Inpatient dprt, Unit of Ther, Rheuma and Cardio Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Medical Center "Universal Clinic "Oberih"" of Limited Liability Company "Capital" Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Limited Liability Company "Medical Centre 'Consilium Medical'", Clinical and Consultation Department Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Medical Center "Harmoniia krasy", LLC Coordinator of this site? Confirm its status | Kyiv | Ukraine | Unknown status |
| Ternopil Regional Clinical Hospital Coordinator of this site? Confirm its status | Ternopil | Ukraine | Unknown status |
| "Medical Center Health Clinic" LLC, Medical Clinical Investigational Center, Department of Cardiology and Rheumatology Coordinator of this site? Confirm its status | Vinnytsia | Ukraine | Unknown status |
| Communal Non-Com Entr Vinnytsia City Clin Hpt 1, Clin Therapy Dprt 2, Vinnytsia Nat Pirogov Memo Med Uni, Dprt of Internal Med 3 Coordinator of this site? Confirm its status | Vinnytsia | Ukraine | Unknown status |
| Precision Comprehensive Clinical Research Solutions Coordinator of this site? Confirm its status | Colleyville | United States | Unknown status |
| Hope Clinical Trials, Inc. Coordinator of this site? Confirm its status | Coral Gables | United States | Unknown status |
| Texas Arthritis Center Coordinator of this site? Confirm its status | El Paso | United States | Unknown status |
| Vital Pharma Research Coordinator of this site? Confirm its status | Hialeah | United States | Unknown status |
| Tectum Medical Research Coordinator of this site? Confirm its status | Hollywood | United States | Unknown status |
| Northwest Houston Arthritis Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Alloy Clinical Research LLC Coordinator of this site? Confirm its status | Kissimmee | United States | Unknown status |
| UCSD Perlman Medical Offices Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
| RB Wellness Clinic Coordinator of this site? Confirm its status | Las Vegas | United States | Unknown status |
| Tandem Clinical Research Coordinator of this site? Confirm its status | Marrero | United States | Unknown status |
| Allied Biomedical Research Institute Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| Professional Research Center, Inc. Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| D&H National Research Centers, Inc Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| San Marcus Research Clinic, Inc. Coordinator of this site? Confirm its status | Miami Lakes | United States | Unknown status |
| Columbia University Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Amicis Research Center Coordinator of this site? Confirm its status | Northridge | United States | Unknown status |
| Tucson Clinical Research Institute, LLC Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
| Panorama Medical Centre Coordinator of this site? Confirm its status | Cape Town | South Africa | Unknown status |
| Arthritis Clinical Research Trials Coordinator of this site? Confirm its status | Cape Town | South Africa | Unknown status |
| Charlotte Maxeke Johannesburg Academic Hospital Coordinator of this site? Confirm its status | Parktown | South Africa | Unknown status |
| University Of Pretoria Coordinator of this site? Confirm its status | Pretoria | South Africa | Unknown status |
| Winelands Medical Research Coordinator of this site? Confirm its status | Somerset West | South Africa | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.